About G1 Therapeutics (GTHX)
G1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing small-molecule therapies for the treatment of cancer. Its two clinical-stage candidates are trilaciclib (G1T28) and G1T38, which are potent, sel... Read more
- USD4.25
- USD4.26
- USD4.13
- USD5.00
- 38.60%
- 83M
- 43.24k
- 927.04k
- 238M
- 1.08
- 62.60%
Stock News
1 hour ago
10 things to watch in the stock market Tuesday: Morgan Stanley beats, Nvidia call
CNBC
1 hour ago
China's inaction on Iran has 'undermined' its influence in the Middle East, analyst says
CNBC
1 hour ago
Alliance Entertainment to Attend Music Biz 2024 in Nashville
Yahoo
1 hour ago
SOLOWIN HOLDINGS Selected as a Key Participating Dealer for Harvest Global’s First Spot Bitcoin and Ethereum ETF in Hong Kong
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
